Abstract
Choroidal neovascularization (CNV) is a rare complication associated with coloboma of the choroid. We describe three cases of coloboma choroid where there was loss of vision due to CNV development at the edge of the coloboma. One was managed by photodynamic therapy alone and two were managed by a combination of reduced fluence PDT and intravitreal bevacizumab. Significantly we noted that one treatment session was sufficient to achieve regression of the CNV and improvement in visual acuity.
MeSH terms
-
Adult
-
Angiogenesis Inhibitors / administration & dosage*
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Choroid / abnormalities*
-
Choroidal Neovascularization / diagnosis
-
Choroidal Neovascularization / drug therapy*
-
Choroidal Neovascularization / etiology*
-
Coloboma / complications*
-
Female
-
Fluorescein Angiography
-
Humans
-
Intravitreal Injections
-
Male
-
Middle Aged
-
Photochemotherapy*
-
Young Adult
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab